Historical Stock Price
|
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ACER Historical Stock Prices |
| Preferred Stock Newsletter |
| ACER Options Chain |
| Stock Message Boards |
Acer Therapeutics (ACER) has the following price history information. Looking back at ACER historical stock prices for the last five trading days, on September 15, 2020, ACER opened at $2.49, traded as high as $2.60 and as low as $2.41, and closed at $2.47. Trading volume was a total of 126.90K shares. On September 16, 2020, ACER opened at $2.47, traded as high as $2.60 and as low as $2.45, and closed at $2.57. Trading volume was a total of 85.70K shares. On September 17, 2020, ACER opened at $2.53, traded as high as $2.74 and as low as $2.49, and closed at $2.54. Trading volume was a total of 259.80K shares. On September 18, 2020, ACER opened at $2.57, traded as high as $2.74 and as low as $2.51, and closed at $2.59. Trading volume was a total of 265.00K shares. On September 21, 2020, ACER opened at $2.55, traded as high as $2.60 and as low as $2.46, and closed at $2.58. Trading volume was a total of 208.50K shares.
ACER Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Acer Therapeutics shares, starting with a $10,000 purchase of ACER, and working forward through the historical stock price information to today.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 09/22/2010 | |
| End date: | 09/21/2020 | |
| Start price/share: | $15.63 | |
| End price/share: | $2.58 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -83.49% | |
| Average Annual Total Return: | -16.48% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $1,649.97 | |
| Years: | 10.01 | |
 | |||||
| ACER Historical Price Range | |||||
| Date | Open | High | Low | Close | Volume |
| 09/15/2020 | $2.49 | $2.60 | $2.41 | $2.47 | 126.90K |
| 09/16/2020 | $2.47 | $2.60 | $2.45 | $2.57 | 85.70K |
| 09/17/2020 | $2.53 | $2.74 | $2.49 | $2.54 | 259.80K |
| 09/18/2020 | $2.57 | $2.74 | $2.51 | $2.59 | 265.00K |
| 09/21/2020 | $2.55 | $2.60 | $2.46 | $2.58 | 208.50K |
|
| About Acer Therapeutics |
| Acer Therapeutics is a pharmaceutical company focused on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Co.'s pipeline includes three clinical-stage candidates: EDSIVO™ (celiprolol) for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001 (a taste-masked, immediate release formulation of sodium phenylbutyrate) for the treatment of various inborn errors of metabolism, including urea cycle disorders and Maple Syrup Urine Disease; and osanetant for the treatment of induced Vasomotor Symptoms where Hormone Replacement Therapy is likely contraindicated. |
| ACER Historical Closing Prices | |
| Date | Close |
| 09/15/2020 | $2.47 |
| 09/16/2020 | $2.57 |
| 09/17/2020 | $2.54 |
| 09/18/2020 | $2.59 |
| 09/21/2020 | $2.58 |
| Healthcare Historical Prices |
| ACER is categorized under the Healthcare sector; below are some other companies in the same sector:
ACET Historical Stock Prices Also explore: ACER shares outstanding history |
